U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261891) titled 'Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders' on June 25.
Brief Summary: The investigators want to study the JAK-inhibitors and their impact on the immune system and evaluate the potential of a gene-therapeutic strategy
Study Start Date: Nov. 21, 2024
Study Type: INTERVENTIONAL
Condition:
Primary Immunodeficiency Diseases (PID)
Intervention:
DIAGNOSTIC_TEST: blood sampling
Blood/serum samples will be collected during routine clinical visits at the time of planned peripheral venous blood sampling. Samples will be processed and either used immediately (flow cytometry-based cel...